INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

287 studies · page 7 of 12

2011 / Interventional trial with sequential treatment and dietary elimination

In children with GERD symptoms not responding to omeprazole, a 4-week elimination of cow's milk resolved all symptoms in all 27 non-responders.

Eighty-one children with signs and symptoms of gastroesophageal reflux disease (GERD) received omeprazole for 4 weeks. Following omeprazole treatment, 54 patients (66.7%) responded well with full symptom resolution. Cow's milk was empirically eliminated for 4 weeks from the diets of the remaining 27 patients who did not respond to omeprazole. All signs and symptoms of GERD resolved in all 27 patients following the 4-week elimination of cow's milk.

Farahmand F, Najafi M, Ataee P, et al. Gut Liver, 2011. PMID 21927657

2011 / Multicenter, randomized, double-blind, cross-over placebo-controlled trial

Aloe vera was not superior to placebo in improving quality of life in patients with irritable bowel syndrome.

In a randomized, double-blind, cross-over study, patients with irritable bowel syndrome were assigned to take 60 mL of Aloe vera or placebo orally twice daily, separated by a washout period. A total of 110 patients were randomized, with 47 completing all questionnaires and both treatment periods. Statistical analysis demonstrated no difference in quality of life outcomes between Aloe vera and placebo. Authors noted that dropouts and other confounding factors may have affected the study's power to detect a clinically meaningful difference.

Hutchings HA, Wareham K, Baxter JN, et al. ISRN Gastroenterol, 2011. PMID 21991499

2011 / Repeated-measure, crossover dietary intervention

Six-week consumption of a wild blueberry drink significantly increased bifidobacteria in the human gut.

A repeated-measure, crossover dietary intervention in human volunteers investigated the effects of consuming a wild blueberry drink versus a placebo drink for six weeks on the intestinal microbiota. Bifidobacterium spp. significantly increased relative to total eubacteria following blueberry treatment (P ≤ 0.05). Lactobacillus acidophilus increased following both treatments (P ≤ 0.05), while no significant differences were observed for Bacteroides spp., Prevotella spp., Enterococcus spp., or Clostridium coccoides.

Vendrame S, Guglielmetti S, Riso P, et al. J Agric Food Chem, 2011. PMID 22060186

2011 / Randomized trials (two crossover, one parallel)

Perceived flatulence from daily bean intake occurred in under half of participants

Three feeding trials assessed gastrointestinal symptoms in adults consuming one-half cup of beans or control daily for 8 to 12 weeks. During the first week, fewer than 50% of participants reported increased flatulence with pinto or baked beans, and only 19% reported increases with black-eyed peas. Across the trials, 3% to 11% of participants also reported heightened flatulence while consuming control diets lacking flatulence-causing ingredients.

Winham DM, Hutchins AM Nutr J, 2011. PMID 22104320

2010 / Randomized double-blind placebo-controlled trial

Delayed-release peppermint oil relieved abdominal pain and improved quality of life in IBS.

A randomized double-blind placebo-controlled study assigned 90 outpatients with irritable bowel syndrome to take enteric-coated peppermint oil capsules or placebo three times daily for 8 weeks. By week 8, 14 participants in the peppermint oil group were free from abdominal pain or discomfort compared with 6 in the control group (P < 0.001). Peppermint oil also significantly reduced abdominal pain severity and improved quality of life, without causing significant adverse reactions.

Merat S, Khalili S, Mostajabi P, et al. Dig Dis Sci, 2010. PMID 19507027

2010 / Randomized controlled trial

A 1-year high-wheat fibre cereal intervention increased plasma SCFA and GLP-1 concentrations in hyperinsulinaemic adults after 9 to 12 months.

Hyperinsulinaemic adults were randomized to consume either a high-wheat fibre cereal (24 g fibre/d; 14 completed) or a low-fibre control cereal (14 completed) daily for 1 year. There were no differences in body weight between groups. After 9 months, baseline-adjusted mean 8 h acetate and butyrate levels were significantly higher on the high-fibre cereal than control (P < 0.05). After 12 months, baseline-adjusted mean plasma GLP-1 in the high-fibre group was 1.3 pmol/l (95% CI 0.4, 2.2; P < 0.05) higher than baseline (~25% increase) and 1.4 pmol/l (95% CI 0.1, 2.7; P < 0.05) higher than the control group.

Freeland KR, Wilson C, Wolever TM Br J Nutr, 2010. PMID 19664300

2010 / Randomized crossover pilot trial

Acetate and rectal infusions increased plasma PYY and GLP-1 while acetate decreased TNF-alpha in hyperinsulinaemic females.

Six hyperinsulinaemic female subjects were given 20 mmol sodium acetate intravenously, 60 mmol acetate rectally, or normal saline rectally or intravenously across four separate occasions in randomized order. Change in plasma PYY was significantly higher after acetate (9.69 pg/ml) versus saline (0.60 pg/ml) and after rectal (13.78 pg/ml) versus intravenous infusions (-3.1 pg/ml; P < 0.01). Change in plasma GLP-1 was increased by rectal and acetate infusions (0.25 and 0.23 mmol/l) versus intravenous and saline (-0.26 and -0.19 mmol/l; P < 0.01). Acetate decreased TNF-alpha compared with saline (-0.8 vs 0.15 pg/ml; P < 0.05), while rectal infusions increased TNF-alpha and ghrelin versus intravenous infusions (P < 0.01); no effect was observed for adiponectin.

Freeland KR, Wolever TM Br J Nutr, 2010. PMID 19818198

2010 / Randomized crossover trial

Eating a meal over 30 minutes significantly increased postprandial responses of PYY and GLP-1 compared to eating it in 5 minutes.

Seventeen healthy adult male volunteers consumed a 300 ml ice cream test meal (675 kcal) in random order across two sessions, taking either 5 minutes or 30 minutes. Peptide YY (PYY) area under the curve (AUC) was significantly higher after the 30-min meal compared to the 5-min meal (5250 +/- 330 vs. 4133 +/- 324 pmol/liter . min, P = 0.004), as was glucagon-like peptide-1 (GLP-1) AUC (8794 +/- 656 vs. 6219 +/- 256 pmol/liter . min, P = 0.001). There was a trend toward higher fullness ratings immediately after the 30-min meal, with no differences observed in ghrelin response.

Kokkinos A, le Roux CW, Alexiadou K, et al. J Clin Endocrinol Metab, 2010. PMID 19875483

2010 / Randomized, single-blind, crossover trial

Adding inulin to a high-fructose corn syrup drink increased serum short-chain fatty acids, lowered free fatty acids, and reduced ghrelin in healthy subjects.

In a randomized, single-blind crossover trial, 12 healthy subjects consumed 400 mL drinks containing 80 g HFCS, 56 g HFCS, or 56 g HFCS plus 24 g inulin, with a standard lunch served at 4 hours. Glucose and insulin responses did not differ significantly between treatments. Serum acetate, propionate, and butyrate were significantly higher from 4 to 6 hours after inulin compared to the HFCS drinks. Free fatty acids were significantly lower after inulin compared to 56HFCS at 4 hours (0.40 +/- 0.06 vs. 0.51 +/- 0.06 mmol*L-1; p < 0.05). Compared with 56HFCS, inulin also significantly increased glucagon-like peptide-1 at 30 minutes and reduced ghrelin at 4.5 and 6 hours.

Tarini J, Wolever TM Appl Physiol Nutr Metab, 2010. PMID 20130660

2010 / Randomized, double-blind, placebo-controlled dose-ranging trial

A proprietary probiotic formula dose-dependently reduced the incidence of antibiotic-associated and Clostridium difficile-associated diarrhea in adult inpatients.

In a dose-ranging study, 255 adult inpatients starting antibiotics were randomized to two probiotic capsules daily (Pro-2, 100 billion c.f.u.), one probiotic plus one placebo capsule daily (Pro-1, 50 billion c.f.u.), or two placebo capsules daily. AAD incidence was 15.5% in Pro-2, 28.2% in Pro-1, and 44.1% in the placebo group; in those who developed AAD, symptom duration was 2.8 days (Pro-2), 4.1 days (Pro-1), and 6.4 days (placebo). CDAD incidence was also reduced: 1.2% in Pro-2, 9.4% in Pro-1, and 23.8% in placebo. Gastrointestinal symptoms were less frequent in the probiotic groups compared to placebo and lower in Pro-2 than in Pro-1.

Gao XW, Mubasher M, Fang CY, et al. Am J Gastroenterol, 2010. PMID 20145608

2010 / Uncontrolled before-and-after trial

In Anisakis-sensitized patients, increased intestinal permeability receded after a 6-month raw fish-free diet.

Researchers screened 540 patients reporting clinical allergy symptoms using skin prick tests for food allergens plus Ani s1 (an A. simplex allergen). A total of 170 subjects had positive skin prick tests, and 87 (51.2%) were positive for Ani s1. Intestinal permeability was measured at baseline and after 6 months of a raw fish-free diet. Increased intestinal permeability observed in sensitized subjects with worse clinical symptoms receded after the 6-month elimination of raw seafood.

Polimeno L, Loiacono M, Pesetti B, et al. Foodborne Pathog Dis, 2010. PMID 20367330

2010 / Open-label crossover trial

Cow's-milk-free diet relieved chronic constipation in over one-third of tested children.

An open-label crossover trial tested cow's milk and rice milk phases in 69 children meeting Rome III criteria for chronic constipation. Overall, 27 of 69 children (39%) developed constipation during milk challenge and improved during milk-free phases, with weekly bowel movements increasing significantly compared with non-responders (2.8 to 7.7 vs 2.6 to 2.7, P < 0.001). Immunologic measures, including total and milk-specific immunoglobulin E, did not differ significantly between responders and non-responders.

Irastorza I, Ibañez B, Delgado-Sanzonetti L, et al. J Pediatr Gastroenterol Nutr, 2010. PMID 20453672

2010 / Randomized controlled trial

Vitamin D3 non-significantly reduced relapse risk in patients with remitted Crohn's disease.

A randomized trial evaluated daily oral supplementation with 1,200 IU vitamin D3 versus placebo over 12 months in 94 patients with Crohn's disease in remission. Vitamin D3 elevated mean serum 25OHD from 69 nmol/L to 96 nmol/L after 3 months (P < 0.001). Clinical relapse occurred in 13% (6/46) of the vitamin D3 group versus 29% (14/48) of the placebo group, which did not reach statistical significance (P = 0.06).

Jørgensen SP, Agnholt J, Glerup H, et al. Aliment Pharmacol Ther, 2010. PMID 20491740

2010 / Crossover intervention trial

A high-total antioxidant capacity diet increased 48-hour stool output and fecal antioxidant levels in human subjects.

Nineteen subjects followed a high-total antioxidant capacity (HT) diet and a low-TAC (LT) diet for 2 weeks in a crossover design, matched for energy, macronutrients, total fiber, and alcohol. Intake of TAC, vitamins E and C, and phenolics increased during the HT diet. The HT diet resulted in greater 48 h stool output (324 [SD 38] g in HT vs. 218 [SD 22] g in LT), along with higher TAC and total phenolic concentrations in fecal water. No significant variations were seen in fecal moisture, pH, ammonia, Lactobacillus and Bifidobacterium counts, or genotoxicity.

Bianchi MA, Scazzina F, Del Rio D, et al. Br J Nutr, 2010. PMID 20579404

2010 / Randomized crossover trial

Barley-based evening meals increased morning plasma butyrate compared with white wheat bread

In a randomized crossover trial, 15 healthy young adults consumed 8 different cereal-based evening test meals containing 50 g available starch on separate nights. Evening meals with high-amylose or high-beta-glucan barley kernels produced higher morning plasma butyrate levels than white wheat bread (P < 0.05). Following a standard breakfast, postprandial glucose response was inversely associated with morning plasma butyrate (r = -0.26; P < 0.01) and acetate (r = -0.20; P < 0.05).

Nilsson AC, Östman EM, Knudsen KE, et al. J Nutr, 2010. PMID 20810606

2010 / Controlled dietary intervention trial

Consuming two green kiwifruits daily for 4 weeks significantly increased defecation frequency and shortened colon transit time in adults with IBS/C.

This 6-week, three-phase study assessed the effect of eating two Hayward green kiwifruits daily for 4 weeks compared to two placebo capsules daily in patients with IBS/C (41 kiwifruit, 13 placebo) along with 16 healthy adults consuming kiwifruit. After the 4-week intervention, weekly defecation frequency significantly increased (p<0.05) and colon transit time significantly decreased (p=0.026) in IBS/C participants who consumed kiwifruit. The findings suggest that consuming kiwifruit for 4 weeks shortens colon transit time and improves bowel function in adults with IBS/C.

Chang CC, Lin YT, Lu YT, et al. Asia Pac J Clin Nutr, 2010. PMID 21147704

2010 / Randomized crossover trial

Chickpea and raffinose supplementation shifted fecal microbial composition in healthy adults.

Twelve healthy adults consumed control, chickpea-supplemented (200 g/day), or raffinose-supplemented (5 g/day) diets for three weeks each in a randomized crossover trial. Both chickpea and raffinose diets increased the abundance of Faecalibacterium prausnitzii compared to control. No significant differences occurred in fecal short-chain fatty acid concentrations, while fewer subjects carried Clostridium histolyticum–lituseburense group bacteria on the chickpea diet.

Fernando WM, Hill JE, Zello GA, et al. Benef Microbes, 2010. PMID 21831757

2010 / Experimental physiological study

Squatting increased the rectoanal angle and lowered basal abdominal pressure before defecation compared to normal sitting in healthy volunteers.

Six healthy volunteers were evaluated in three defecation positions: sitting, sitting with hips flexed at 60°, and squatting with hips flexed at 22.5°. Basal abdominal pressure before defecation during squatting (26 cmH2O) was significantly lower than during normal sitting (P < 0.01). The rectoanal angle during defecation while squatting (126°) was significantly larger than during normal sitting (100°, P < 0.05) and hip-flex sitting (99°, P < 0.01). Differences in abdominal pressure increase (strain) between positions did not reach statistical significance.

Sakakibara R, Tsunoyama K, Hosoi H, et al. Low Urin Tract Symptoms, 2010. PMID 26676214

2009 / Randomized controlled trial

A very low-carbohydrate diet reduced stool output and fecal short-chain fatty acids.

Ninety-one overweight or obese adults followed an energy-restricted low-carbohydrate or high-carbohydrate diet for 8 weeks. Compared with the high-carbohydrate plan, the low-carbohydrate diet significantly reduced fecal output, defecation frequency, butyrate concentrations (-3.9 vs. -0.5 mmol/l), total short-chain fatty acids (-15.8 vs. 1.4 mmol/l), and bifidobacteria counts. Both diets showed similar self-reported gastrointestinal tolerance and adverse symptom rates.

Brinkworth GD, Noakes M, Clifton PM, et al. Br J Nutr, 2009. PMID 19224658

2009 / Randomized, double-blind, placebo-controlled pilot study

Daily Lactobacillus casei strain Shirota for two months significantly reduced anxiety symptoms in chronic fatigue syndrome patients.

In this pilot study, 39 chronic fatigue syndrome patients were randomized to receive either 24 billion colony forming units of Lactobacillus casei strain Shirota (LcS) or a placebo daily for two months. Patients provided stool samples and completed the Beck Depression and Beck Anxiety Inventories before and after treatment. There was a significant rise in both Lactobacillus and Bifidobacteria in the LcS group, along with a significant decrease in anxiety symptoms compared to controls (p = 0.01).

Rao AV, Bested AC, Beaulne TM, et al. Gut Pathog, 2009. PMID 19338686

2009 / Prospective comparative study with matched groups

Active vitamin D linked to short-term bone marker improvements in Crohn's disease

A prospective study followed 37 inactive Crohn's disease patients in two matched groups receiving either active or plain vitamin D. At six weeks, the active form was linked to lower disease activity index values (69.44 vs 57.0) and C-reactive protein (15.8 vs 7.81 mmol/L, P < 0.05). Markers of bone turnover also decreased and osteoprotegerin rose with the active form. These biochemical changes were stronger at three months but disappeared by month 12.

Miheller P, Muzes G, Hritz I, et al. Inflamm Bowel Dis, 2009. PMID 19408329

2009 / Double-blind, placebo-controlled crossover trial

In patients with atopic dermatitis, consuming mare's milk significantly reduced mean SCORAD scores at 12 weeks.

A double-blind, placebo-controlled crossover trial evaluated the consumption of 250 ml mare's milk or placebo for 16 weeks in 23 patients with atopic dermatitis. The mean SCORAD value decreased from 30.1 to 25.3 after 12 weeks (P<0.05) and to 26.7 after 16 weeks (P<0.1) during the mare's milk period. In a subgroup of 7 patients, the SCORAD index and pruritus decreased by 30% (P<0.01), accompanied by an increase in faecal bifidobacteria from 4.6% to 11.9% of eubacteria (P<0.05). Immunological parameters remained unchanged, with the exception of C-reactive protein.

Foekel C, Schubert R, Kaatz M, et al. Int J Food Sci Nutr, 2009. PMID 19462320

2009 / Randomized, double-blind, parallel, placebo-controlled trial

Prebiotic supplementation increased breath-hydrogen, boosted GLP-1 and PYY, lowered hunger, and reduced postprandial glucose in healthy adults.

Ten healthy adults were randomly assigned to receive either 16 g prebiotics/d or 16 g dextrin maltose/d for 2 weeks. Prebiotic treatment increased breath-hydrogen excretion approximately 3-fold, lowered hunger rates, and increased plasma glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) concentrations while decreasing postprandial glucose responses. Areas under the curve for postprandial GLP-1 and breath-hydrogen were significantly correlated (r = 0.85, P = 0.007), and glucose response was inversely correlated with breath-hydrogen AUC (r = -0.73, P = 0.02).

Cani PD, Lecourt E, Dewulf EM, et al. Am J Clin Nutr, 2009. PMID 19776140

2008 / Randomized controlled trial

Enteral probiotics did not reduce infection and increased mortality in severe acute pancreatitis.

In a double-blind trial, 296 patients with predicted severe acute pancreatitis received a multispecies probiotic preparation or placebo twice daily for 28 days. Infectious complications occurred in 30% of the probiotic group and 28% of the placebo group (relative risk 1.06, 95% CI 0.75-1.51). Mortality was higher with probiotics at 16% versus 6% for placebo (relative risk 2.53, 95% CI 1.22-5.25), alongside nine cases of bowel ischaemia.

Besselink MG, van Santvoort HC, Buskens E, et al. Lancet, 2008. PMID 18279948